MVA p53 vaccine (Tara Immuno-Oncology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMVA p53 vaccine (Tara Immuno-Oncology)
Drug Alias Namep53MVA vaccine (Tara Immmuno-Oncology)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulatorsTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsGastrointestinal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesTara Immuno-Oncology LLCNational Cancer InstituteCity Of Hope National Medical Center
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsGastrointestinal Neoplasms
Inactive IndicationsFallopian Tube NeoplasmsPeritoneal NeoplasmsCarcinoma, Ovarian Epithelial

Other Information

ATC CodeN/A
Related LinksN/A